Form 4: Repligen CEO Sells Shares for Tax Obligations
Insider Transaction Report
Repligen CEO Olivier Loeillot disposed of common stock shares to cover tax withholding obligations related to restricted stock unit releases.
Summary
- Olivier Loeillot, CEO and Director of Repligen Corp, reported changes in beneficial ownership of common stock.
- On February 27, 2026, 344 shares were disposed of at a price of $128.73 per share.
- On March 2, 2026, an additional 1,610 shares were disposed of at a price of $124.97 per share.
- These dispositions were made to satisfy tax withholding obligations arising from the release of restricted stock units.
- Following these transactions, Olivier Loeillot beneficially owns 33,944 shares of Repligen Common Stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transactions are routine tax-related dispositions of shares from restricted stock units, not indicative of a change in sentiment or strategic shift.
Positives
- The transactions are routine and expected for executives receiving restricted stock units, indicating a normal compensation event rather than a discretionary sale.
Negatives
- The disposition of shares, even for tax purposes, reduces the CEO's direct ownership stake in the company by 1,954 shares.
Industry Context
StockSavvy.ai notes that these types of transactions are common for executives receiving equity compensation, particularly restricted stock units, where a portion of the shares is often sold to cover tax liabilities upon vesting. This is a standard practice across various industries and does not inherently signal a change in management's confidence in the company's future, unlike open market sales.
Comparison to Industry Standards
- These tax-related dispositions are a standard practice for executives across the biotech and life sciences industry, similar to how executives at companies like Danaher or Thermo Fisher Scientific manage their equity compensation.
- The volume of shares disposed (1,954 shares total) is relatively small compared to the CEO's remaining beneficial ownership of 33,944 shares, which is typical for tax withholding events.
Stakeholder Impact
- Shareholders: Minimal direct impact as these are routine tax-related sales, not a discretionary sale indicating a lack of confidence. The CEO's overall stake remains substantial.
Key Dates
| Date | Description |
|---|---|
| 02/27/2026 | Date of transaction for disposition of 344 shares of common stock. |
| 03/02/2026 | Date of transaction for disposition of 1,610 shares of common stock. |
| 03/03/2026 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThe reported transactions are routine tax-related dispositions of shares by the CEO, which is a common occurrence when restricted stock units vest. This event does not provide new information that would fundamentally alter the investment thesis for Repligen Corp, nor does it signal a change in management's confidence. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on the company's underlying fundamentals rather than this specific insider filing.
Keywords
Repligen, RGEN, SEC Form 4, Insider Trading, Stock Sale, CEO, Olivier Loeillot, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.